Mikhail Blagosklonny Research on Life Longitivity

Mikhail Blagosklonny is a philanthropist, researcher and an Oncology professor at the Roswell Park Cancer Institute since 2002. He works at the Department of Cell Stress Biology on cancer biomarkers and cell proliferation. He is a scientist and carries out research and studies on cancer and aging. He received an MD in Internal Medicine, cardiology, and Ph.D. in Experimental Medicine from the First Pavlov State Medical University of St. Petersburg. His research interests include Biogerontology, cancer, and its therapies and anti-aging drugs. He mostly targets the cancer therapies that protect the healthy living cells against any damage. He also works as Oncotarget’s Editor-in-chief.

He is a member of the editorial board of Cell Death and Differentiation. Mikhail Blagosklonny is the writer of aging Hyperfunction theory and has taken a very keen interest in oncology. He believes that it is possible to control aging and cure cancer without injuring the other normal body cells responsible for the recovering the body and mind of the patients after recovery. He came up with a proposal on the use of Rapamycin in cancer treatment and as an anti-aging drug. He also believes in a disease-free world that is why he has dedicated his time to research on best and cheaper cancer treatments so that everyone can be able to afford it. Mikhail Blagosklonny has over 300 publications under his name, and he is among the biggest researchers of oncology in the world. Furthermore, is a partner editor for the American Journal of Cancer, PLOS ONE, and International Journal of Cancer.

Mikhail is interested in cancer, aging, and the relationship between the two. He studies why cancer is most common in older people and uses the Rapamycin drug in increasing the life-span of the human beings. Rapamycin drug has numerous advantages in the medical field. It is used as an immunosuppressant during organ transplants as it is known to have a lower level of toxicity towards transplanted organs such as kidneys. It is also used in cancer treatment through improving and directing the immune system towards cancer tumors and cells. It also has the capability of reducing cancer in people with organ transplant.

Mikhail Blagosklonny is currently conducting research on how Rapamycin drug is increasing life-span of humans. He has carried out several tests on mice that have shown when mice are given the drug they have a higher immunity ability to fight diseases such as Tuberculosis. Several initial tests on humans have shown that the drug helps in the regeneration of cells and organs in elder people when they were injected with the drug prior to influenza vaccination. Scientists are currently carrying out research tests on the marmoset monkey to find out if the drug increases life-span. There are some research on the use of the Rapamycin drug on treatments of several diseases in humans. Initial test results on mice have proven to be very encouraging, and scientists have high hopes that the drug can be used on humans to increase life-span, treat Alzheimer’s disease, muscular dystrophy, and Systematic Lupus Erythematosus (SLE). Dr. Mikhail Blagosklonny has played a significant role in the pioneer of the research being carried out by the scientist.

Leave a Reply

Post Navigation